Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

NCT04793932 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

261

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Ductal Adenocarcinoma

Interventions

DRUG: PAXG
DRUG: mFOLFIRINOX
DRUG: short-course chemotherapy
DRUG: long-course chemotherapy

Sponsor

Associazione Italiana per lo Studio del Pancreas

Collaborators

[object Object]
[object Object]